Making Licensed Product Sample Clauses

Making Licensed Product. Subject to the terms and conditions of this Agreement, TWTI hereby grants to ACLA a worldwide, non-exclusive, license, with no right to grant or authorize sublicenses, under the TWTI IP to create Licensed Products in the Genotyping Field ("Genotyping Products") solely by bundling together to form the Genotyping Products (i) Probe Sets manufactured by ACLA under Section 3.5(a); (ii) Cleavase Enzyme obtained or manufactured by ACLA pursuant to the Supply Agreement; and (iii) buffers, salts, or other reagents (e.g. cofactors and controls, but excluding Cleavage Enzymes not obtained under the Supply Agreement) reasonably necessary or useful to perform the applicable Multiplexed Invader Application for which the Genotyping Product is designed. For clarity, no have made rights are granted under this Section 3.5(b).
Sample 1Sample 2
AutoNDA by SimpleDocs
Making Licensed Product. Subject to the terms and conditions of this Agreement, TWTI hereby grants to ACLA a worldwide, non-exclusive, royalty bearing license under the TWTI IP to make Licensed Products in the Gene Expression Field solely by bundling together to form the Licensed Product (i) Probe Sets manufactured by ACLA, or its contract manufacturer, under Section 3.1(a); (ii) Cleavase Enzyme obtained or manufactured by ACLA pursuant to the Supply Agreement; and (iii) buffers, salts or other reagents (e.g. cofactors and controls, but excluding Cleavage Enzymes not obtained pursuant to the Supply Agreement) ______________ *** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. reasonably necessary or useful to perform the applicable Multiplexed Invader Application for which the Licensed Product is designed. ACLA shall have no right to grant or authorize sublicenses under this Section 3.1(b) except to the extent expressly set forth in Sections 3.2(d) and 3.2(e) below. For clarity, no have made rights are granted under this Section 3.1(b).
Sample 1
Making Licensed Product. Subject to the terms and conditions of this Agreement, TWTI hereby grants to ACLA a worldwide, non-exclusive, royalty bearing license under the TWTI IP to make Licensed Products in the Gene Expression Field solely by bundling together to form the Licensed Product (i) Probe Sets manufactured by ACLA, or its contract manufacturer, under Section 3.1(a); (ii) Cleavase Enzyme obtained or manufactured by ACLA pursuant to the Supply Agreement; and (iii) buffers, salts or other reagents (e.g. cofactors and controls, but excluding Cleavase Enzymes not obtained pursuant to the Supply Agreement) reasonably necessary or useful to perform the applicable Multiplexed Invader Application for which the Licensed Product is designed. ACLA shall have no right to grant or authorize sublicenses under this Section 3.1(b) except to the extent expressly set forth in Sections 3.2(d) and 3.2(e) below. For clarity, no have made rights are granted under this Section 3.1(b).
Sample 1

Related to Making Licensed Product

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Manufacturing License Subject to the terms of this Agreement, including without limitation Section 2.2, Theravance grants to GSK an exclusive license under the Theravance Patents and Theravance Know-How to make and have made API Compound or formulated Alliance Product in the Territory.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Product The term “

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Regulatory Approval Any waiting period applicable to the Transactions under the HSR Act shall have been terminated or shall have expired.

Time is Money Join Law Insider Premium to draft better contracts faster.